Skip to content
10-Q

Quarterly Report

BETA BIONICS, INC. BBNX

0001193125-26-166843

← back to feed
Filed
Apr 21, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 16, 2026 44.56M sh
Shares Diluted Q1 2026 · Mar 31, 2026 44.44M sh
Shares Diluted Q1 2026 · Mar 31, 2025 30.71M sh
Capex Q1 2026 · Mar 31, 2026 $1.38M
Capex Q1 2026 · Mar 31, 2025 $333K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$23.83M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$19.98M
Short Term Investments Q1 2026 · Mar 31, 2026 $169.31M
Short Term Investments Q1 2026 · Dec 31, 2025 $187.55M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $30.21M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $31.58M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $42.45M
Stockholders Equity Q1 2026 · Mar 31, 2026 $271.25M
Stockholders Equity Q1 2026 · Dec 31, 2025 $287.61M
Stockholders Equity Q1 2026 · Mar 31, 2025 $313.75M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$245.36M
Current Liabilities Q1 2026 · Mar 31, 2026 $23.19M
Current Liabilities Q1 2026 · Dec 31, 2025 $30.92M
Total Liabilities Q1 2026 · Mar 31, 2026 $33.17M
Total Liabilities Q1 2026 · Dec 31, 2025 $41.13M
Current Assets Q1 2026 · Mar 31, 2026 $247.99M
Current Assets Q1 2026 · Dec 31, 2025 $267.91M
Total Assets Q1 2026 · Mar 31, 2026 $304.42M
Total Assets Q1 2026 · Dec 31, 2025 $328.74M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.49
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.93
Eps Basic Q1 2026 · Mar 31, 2026 −$0.49
Eps Basic Q1 2026 · Mar 31, 2025 −$0.93
Sga Expense Q1 2026 · Mar 31, 2026 $9.62M
Sga Expense Q1 2026 · Mar 31, 2025 $6.62M
Rd Expense Q1 2026 · Mar 31, 2026 $10.36M
Rd Expense Q1 2026 · Mar 31, 2025 $7.59M
Net Income Q1 2026 · Mar 31, 2026 −$21.9M
Net Income Q1 2026 · Mar 31, 2025 −$28.66M
Operating Income Q1 2026 · Mar 31, 2026 −$24.27M
Operating Income Q1 2026 · Mar 31, 2025 −$18.64M
Gross Profit Q1 2026 · Mar 31, 2026 $16.44M
Gross Profit Q1 2026 · Mar 31, 2025 $8.97M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $11.19M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $8.67M
Revenue Q1 2026 · Mar 31, 2026 $27.63M
Revenue Q1 2026 · Mar 31, 2025 $17.64M